摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-benzenesulfonyl-phenol | 92368-25-7

中文名称
——
中文别名
——
英文名称
3-benzenesulfonyl-phenol
英文别名
3-Benzolsulfonyl-phenol;Phenyl-(3-hydroxy-phenyl)-sulfon;3-Hydroxy-1-phenylsulfon-benzol;3-Phenylsulfon-phenol;m-Hydroxyphenyl-phenyl-sulfon;3-Hydroxy-diphenylsulfon;3-(Benzenesulfonyl)phenol
3-benzenesulfonyl-phenol化学式
CAS
92368-25-7
化学式
C12H10O3S
mdl
——
分子量
234.276
InChiKey
XJOOTLNQYINUQK-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    163-163.5 °C
  • 沸点:
    453.8±28.0 °C(Predicted)
  • 密度:
    1.329±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2
  • 重原子数:
    16
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    62.8
  • 氢给体数:
    1
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Acid-catalysed aromatisation of benzene cis-1,2-dihydrodiols: a carbocation transition state poorly stablised by resonance
    作者:Derek R. Boyd、John Blacker、Briege Byrne、Howard Dalton、Mark V. Hand、Sandra C. Kelly、Rory A. More O'ferrall、S. Nagaraja Rao、Narain D. Sharma、G. N. Sheldrake
    DOI:10.1039/c39940000313
    日期:——
    Acid-catalysed dehydration of 3-substituted benzene cis-1,2-dihydrodiols exhibits a Hammett plot with ρ=–8.2, consistent with reaction via a benzenonium ion-like intermediate; however, correlation of +M resonance substituents such as Me and MeO by σp rather than σ+ constants indicates a marked imbalance between resonance and inductive stabilisation of the transition state.
    酸催化下3-取代苯顺-1,2-二氢二醇的脱水反应呈现出ρ=–8.2的哈米特图,这与通过类似苯镝离子中间体的反应途径一致;然而,通过σp而非σ+常数关联甲基和甲氧基等+M共振取代基,表明过渡态的共振与诱导稳定之间存在明显失衡。
  • Intermediate of 6-Substituted 1-Methyl-1-H-Benzimidazole Derivative and Method for Producing Same
    申请人:Kajino Hisaki
    公开号:US20090023929A1
    公开(公告)日:2009-01-22
    A method for preparing a compound having the following formula (I) by reducing a nitro group of the following formula (III) followed by carrying out an intramolecular dehydration condensation, wherein R 2 is hydrogen, alkyl, cycloalkyl, phenyl or a 5- or 6-membered heterocyclic, and X is oxygen, sulfur or nitrogen.
    一种制备具有以下化学式(I)的化合物的方法,包括还原以下化学式(III)的硝基,然后进行分子内脱水缩合反应,其中R2是氢、烷基、环烷基、苯基或5-或6-成员杂环基,X是氧、硫或氮。
  • Intermediate of 6-substituted-1-methyl-1-H-benzimidazole derivative and method for producing same
    申请人:Kajino Hisaki
    公开号:US20100234612A1
    公开(公告)日:2010-09-16
    A compound having the following formula (III) wherein R 2 is hydrogen, alkyl, cycloalkyl, phenyl or a 5- or 6-membered heterocyclic, and X is oxygen, sulfur or nitrogen, and a method for preparing said compound.
    一种具有以下式子(III)的化合物,其中R2是氢、烷基、环烷基、苯基或5-或6-成员杂环,X是氧、硫或氮,以及制备该化合物的方法。
  • Fungicides
    申请人:ZENECA LIMITED
    公开号:EP0307103A2
    公开(公告)日:1989-03-15
    Fungicidal compounds of the formula (I) : and stereoisomers thereof, wherein K is oxygen or sulphur; Z is optionally substituted aryl or optionally substituted heteroaryl; X is 0, S(O)n, NR4, CR'R2, CHRS, CO, CR'(OR2), C=CR1R2, CHR1CHR2, CR' =CR2, CHR1CR2=CH, C-C, OCHR', CHR'O, OCHR'O, S(O)nCHR', S(O)nCHR'O, CHR'S(0)n, CHR1OSO2, NR4CHR1, CHR1NR4, C02, 02C, S020, OSO2, CO.CO, COCHR', COCHR'O, CHR'CO, CHOH.CHR1, CHR'.CHOH, CONR4, OCONR4, NR4CO, CSNR4, OCS.NR4, SCO.NR4, NR4CO2, NR4CS, NR4CSO, NR4COS, NR4CONR4, S(O)nNR4, NR4S(O)n, CS2, S2C, CO.S, SCO, N=N, N=CR1, CR1=N, CHR1CHR2CH(OH), CHR'OCO, CHR'SCO, CHR1NR4CO, CHR'NR4COR4, CHR'CHR2CO, O.N=CR', CHR1O.N=CR2, CO.OCR'R2, CHR'CHR2CHR3, OCHR1CHR2, (CH2)mO, CHR1OCHR2, CHR'CHR20, OCHR'CHR20, S(O)-nCHR1CHR1, CHR1S(O)nCHR2, CHR'CHR2S(O)n. CR1=NNR4. NR4N=CR1, CHR1CONR2, CHR1OCO.NR2, CH=CHCH2O, COCHR1CHR2O or (R5)2P+CHR2Q-; A, B and E, which may be the same or different, are H, hydroxy, halo, C1-4 alkyl, C1-4 alkoxy, C1-4 haloalkyl, C1-4 haloalkoxy, C1-4 alkylcarbonyl, C1-4 alkoxycarbonyl, phenoxy, nitro or cyano; R', R2 and R3, which may be the same or different, are H, C1-4 alkyl or phenyl; R4 is H, C1-4 alkyl or COR'; R5 is optionally substituted phenyl; Q- is a halide anion; n is 0, 1 or 2 and m is a 3, 4 or 5; except that when Z is unsubstituted phenyl and X and K are oxygen, A, B and E are not all hydrogen.
    式 (I) : 及其立体异构体,其中 K 是氧或硫;Z 是任选取代的芳基或任选取代的杂芳基;X 是 0、S(O)n、NR4、CR'R2、CHRS、CO、CR'(OR2)、C=CR1R2、CHR1CHR2、CR' =CR2、CHR1CR2=CH、C-C、OCHR'、CHR'O、OCHR'O、S(O)nCHR'、S(O)nCHR'O、CHR'S(0)n、CHR1OSO2、NR4CHR1、CHR1NR4、C02、02C、S020、OSO2、CO.CO、COCHR'、COCHR'O、CHR'CO、CHOH.CHR1、CHR'.CHOH、 CONR4、OCONR4、NR4CO、CSNR4、OCS.NR4、SCO.NR4、NR4CO2、NR4CS、NR4CSO、NR4COS、NR4CONR4、S(O)nNR4、NR4S(O)n、CS2、S2C、CO.S、SCO、N=N、N=CR1、CR1=N、CHR1CHR2CH(OH)、CHR'OCO、CHR'SCO、CHR1NR4CO、CHR'NR4COR4、CHR'CHR2CO、O。N=CR',CHR1O.N=CR2,CO.OCR'R2,CHR'CHR2CHR3,OCHR1CHR2,(CH2)mO,CHR1OCHR2,CHR'CHR20,OCHR'CHR20,S(O)-nCHR1CHR1,CHR1S(O)nCHR2,CHR'CHR2S(O)n。CR1=NNR4。NR4N=CR1,CHR1CONR2,CHR1OCO。NR2、CH=CHCH2O、COCHR1CHR2O 或 (R5)2P+CHR2Q-;A、B 和 E 可以相同或不同,它们是 H、羟基、卤代、C1-4 烷基、C1-4 烷氧基、C1-4 卤代烷基、C1-4 卤代烷氧基、C1-4 烷基羰基、C1-4 烷氧基羰基、苯氧基、硝基或氰基;R'、R2 和 R3(可以相同或不同)是 H、C1-4 烷基或苯基;R4 是 H、C1-4 烷基或 COR';R5 是任选取代的苯基;Q- 是卤化阴离子;n 是 0、1 或 2,m 是 3、4 或 5;但当 Z 是未取代的苯基且 X 和 K 是氧时,A、B 和 E 并非都是氢。
  • INTERMEDIATE OF 6-SUBSTITUTED-1-METHYL-1-H-BENZIMIDAZOLE DERIVATIVE AND METHOD FOR PRODUCING SAME
    申请人:Sankyo Company, Limited
    公开号:EP1798216A1
    公开(公告)日:2007-06-20
    [Subject] The object of the present invention is to provide new intermediates (IIa) and (III) of the 6-substituted-1-methyl-1-H-benzimidazol derivatives (I) which are publicly known pharmaceutically active ingredients, and a preparation procedure suitable for a large scale synthesis of N-(5-substituted-2-nitrophenyl)-N-methylamines (II) which are synthetic intermediates. Additionally, another object of the present invention is to provide an efficient procedure for the preparation of the 6-substituted-1-methyl-1-H-benzimidazole derivative (I) from said synthetic intermediates (II) in a shorter number of steps. [Measures to solve the subject] The present invention relates to a procedure for the preparation of a compound (I) represented by the following formula and synthetic intermediates of said compound (I). (In the above reaction scheme, R2 represents a phenyl group which may optionally be substituted with substituents such as a C1-C6 alkyl group or the like, and X represents an oxygen atom, a sulfur atom or a nitrogen atom).
    主题 本发明的目的是提供6-取代-1-甲基-1-H-苯并咪唑衍生物(I)的新中间体(IIa)和(III),它们是公开已知的药物活性成分,以及一种适合大规模合成N-(5-取代-2-硝基苯基)-N-甲基胺(II)的合成中间体的制备程序。 此外,本发明的另一个目的是提供一种高效的程序,以较少的步骤从上述合成中间体(II)制备 6-取代-1-甲基-1-H-苯并咪唑衍生物(I)。 [解决措施] 本发明涉及一种制备下式代表的化合物(I)和所述化合物(I)的合成中间体的程序。 (在上述反应方案中,R2 代表苯基,可任选被 C1-C6 烷基等取代基取代,X 代表氧原子、硫原子或氮原子)。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐